CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged donor cells take on stubborn lymphomas
Disease control Recruiting nowThis early-stage study tests a new type of cell therapy for people with certain lymphomas that have come back or not responded to treatment. The therapy uses immune cells from healthy donors that are modified to better recognize and attack cancer cells, plus an added molecule to …
Matched conditions: CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
New immune therapy targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-stage trial tests a new treatment for people with certain blood cancers (like Hodgkin lymphoma) that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in the lab to better attack cancer cells. The m…
Matched conditions: CD30-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 11, 2026 20:47 UTC